Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (251-260 of 283) with videos related to

Pageof 29
Sort By:
Nature Communications|June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneityRouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
Cell Reports|October 26, 2018
The Cdkn1a<sup>SUPER</sup> Mouse as a Tool to Study p53-Mediated Tumor SuppressionAlessandro Torgovnick, Jan Michel Heger, Vasiliki Liaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell CancersFriederike Göke, Alina Franzen, Trista K Hinz, et al.
Journal of Hematology & Oncology|March 18, 2023
Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivoSandra Genduso, Vera Freytag, Daniela Schetler, et al.
Journal of the National Cancer Institute|May 29, 2008
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancerSunita R Setlur, Kirsten D Mertz, Yujin Hoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck CancerPeter Weber, Axel Künstner, Julia Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
mRNA expression signature of Gleason grade predicts lethal prostate cancerKathryn L Penney, Jennifer A Sinnott, Katja Fall, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2012
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancerHans-Ulrich Schildhaus, Lukas C Heukamp, Sabine Merkelbach-Bruse, et al.
The American Journal of Surgical Pathology|July 15, 2021
IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable OutcomeStefanie Glöss, Philipp Jurmeister, Anne Thieme, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Pageof 29

Showing results (251-260 of 283) with videos related to

Sort By:
Pageof 29
Nature Communications|June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneityRouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
Cell Reports|October 26, 2018
The Cdkn1a<sup>SUPER</sup> Mouse as a Tool to Study p53-Mediated Tumor SuppressionAlessandro Torgovnick, Jan Michel Heger, Vasiliki Liaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell CancersFriederike Göke, Alina Franzen, Trista K Hinz, et al.
Journal of Hematology & Oncology|March 18, 2023
Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivoSandra Genduso, Vera Freytag, Daniela Schetler, et al.
Journal of the National Cancer Institute|May 29, 2008
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancerSunita R Setlur, Kirsten D Mertz, Yujin Hoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck CancerPeter Weber, Axel Künstner, Julia Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
mRNA expression signature of Gleason grade predicts lethal prostate cancerKathryn L Penney, Jennifer A Sinnott, Katja Fall, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2012
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancerHans-Ulrich Schildhaus, Lukas C Heukamp, Sabine Merkelbach-Bruse, et al.
The American Journal of Surgical Pathology|July 15, 2021
IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable OutcomeStefanie Glöss, Philipp Jurmeister, Anne Thieme, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Pageof 29